1. Home
  2. AUPH vs BFLY Comparison

AUPH vs BFLY Comparison

Compare AUPH & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • BFLY
  • Stock Information
  • Founded
  • AUPH 1993
  • BFLY 2011
  • Country
  • AUPH Canada
  • BFLY United States
  • Employees
  • AUPH N/A
  • BFLY N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • BFLY Medical Electronics
  • Sector
  • AUPH Health Care
  • BFLY Health Care
  • Exchange
  • AUPH Nasdaq
  • BFLY Nasdaq
  • Market Cap
  • AUPH 999.8M
  • BFLY 1.1B
  • IPO Year
  • AUPH 1999
  • BFLY N/A
  • Fundamental
  • Price
  • AUPH $7.85
  • BFLY $2.29
  • Analyst Decision
  • AUPH Strong Buy
  • BFLY Strong Buy
  • Analyst Count
  • AUPH 2
  • BFLY 2
  • Target Price
  • AUPH $11.50
  • BFLY $4.00
  • AVG Volume (30 Days)
  • AUPH 1.1M
  • BFLY 2.4M
  • Earning Date
  • AUPH 05-12-2025
  • BFLY 05-02-2025
  • Dividend Yield
  • AUPH N/A
  • BFLY N/A
  • EPS Growth
  • AUPH N/A
  • BFLY N/A
  • EPS
  • AUPH 0.27
  • BFLY N/A
  • Revenue
  • AUPH $247,295,000.00
  • BFLY $85,625,000.00
  • Revenue This Year
  • AUPH $11.86
  • BFLY $21.09
  • Revenue Next Year
  • AUPH $24.96
  • BFLY $25.79
  • P/E Ratio
  • AUPH $29.71
  • BFLY N/A
  • Revenue Growth
  • AUPH 29.20
  • BFLY 25.77
  • 52 Week Low
  • AUPH $4.98
  • BFLY $0.67
  • 52 Week High
  • AUPH $10.67
  • BFLY $4.98
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 44.68
  • BFLY 45.29
  • Support Level
  • AUPH $7.89
  • BFLY $2.10
  • Resistance Level
  • AUPH $8.49
  • BFLY $2.34
  • Average True Range (ATR)
  • AUPH 0.30
  • BFLY 0.14
  • MACD
  • AUPH -0.02
  • BFLY 0.02
  • Stochastic Oscillator
  • AUPH 36.95
  • BFLY 42.22

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

Share on Social Networks: